{"id":248704,"date":"2026-09-16T11:50:08","date_gmt":"2026-09-16T06:20:08","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=248704"},"modified":"2026-09-16T11:50:11","modified_gmt":"2026-09-16T06:20:11","slug":"nath-bio-genes-india-bull-case-vs-bear-case-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/nath-bio-genes-india-bull-case-vs-bear-case-2026\/","title":{"rendered":"Nath Bio-Genes (India) Share: Bull Case vs Bear Case for 2026"},"content":{"rendered":"
<\/div>\n
\n

Nath Bio-Genes (India) Key Stats (16 Sep 2026)<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Sector<\/td>\nSeeds and Agricultural Biotechnology<\/td>\n<\/tr>\n
Current Market Price<\/td>\nRs 147.10<\/td>\n<\/tr>\n
52 Week High \/ Low<\/td>\nRs 204.00 \/ Rs 126.15<\/td>\n<\/tr>\n
Market Cap (Rs Cr)<\/td>\n279<\/td>\n<\/tr>\n
P\/E Ratio (Industry P\/E)<\/td>\n7.21 (35.12)<\/td>\n<\/tr>\n
Return on Equity<\/td>\n5.32%<\/td>\n<\/tr>\n
Debt to Equity<\/td>\n0.20<\/td>\n<\/tr>\n
EPS (TTM)<\/td>\nRs 20.35<\/td>\n<\/tr>\n
Dividend Yield<\/td>\n1.36%<\/td>\n<\/tr>\n
Book Value<\/td>\nRs 358.06<\/td>\n<\/tr>\n
14 Day RSI<\/td>\n36.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n

Quick Answer<\/strong><\/p>\n

The Nath Bio-Genes (India) bull case rests on extraordinarily deep discount to industry valuation, while the bear case points to sharp single session rally but off highs. At Rs 147.10, the stock sits between its 52 week low of Rs 126.15 and high of Rs 204.00, and both sides of the argument deserve a look before deciding. This article lays out the fundamentals and technical signals so you can weigh the Nath Bio-Genes (India) bull case against the risks yourself.<\/p>\n<\/div>\n

Nath Bio-Genes (India)<\/a> operates in the seeds and agricultural biotechnology space, and its shares currently trade at Rs 147.10, placing the stock within a 52 week range of Rs 126.15 to Rs 204.00. For anyone building or reviewing a position, the Nath Bio-Genes (India) bull case and the bear case both come down to the same underlying numbers read in different lights, and this piece walks through both sides using the company’s latest valuation, profitability, and technical readings.<\/p>\n

Rather than pushing you toward one conclusion, this Nath Bio-Genes (India) bull case analysis sets out what the bulls see in Nath Bio-Genes (India) shares and what the bears are watching, so you can match the picture against your own risk appetite and investment horizon. Understanding the Nath Bio-Genes (India) bull case thoroughly, alongside its counterpart, is essential before making any investment decision.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n